A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects

Phase 1 Completed 40 enrolled Transcend Therapeutics

Non-randomizedSequentialOpen-labelTreatment

This is an open-label, single, ascending dose study evaluating the PK and safety of methylone in healthy subjects.

Evaluation	Drug	Modality	Dose	Route
Subject	Methylone	Other / unclassified	50 mg	Oral
Subject	Methylone	Other / unclassified	100 mg	Oral
Subject	Methylone	Other / unclassified	150 mg	Oral
Subject	Methylone	Other / unclassified	200 mg	Oral